Provigil Cost in Delaware 2026: Modafinil Prices, Insurance, and Compounding Options

What Is the Actual Cash Price of Provigil and Generic Modafinil in Delaware?

Brand-name Provigil retails near $850 per month in Delaware without insurance. Generic modafinil, which carries the same active ingredient and bioequivalence data accepted by the FDA, averages about $80 per month at Delaware retail pharmacies in 2026. The gap between brand and generic exists entirely because of patent expiration, not any difference in the drug itself.

Modafinil received FDA approval for narcolepsy in 1998 after the US Modafinil in Narcolepsy Study Group demonstrated statistically significant improvements in the Maintenance of Wakefulness Test and the Epworth Sleepiness Scale compared with placebo [1]. That approval established the clinical foundation that later supported its use in obstructive sleep apnea (OSA) and shift-work sleep disorder (SWSD) [2].

Because modafinil is a Schedule IV controlled substance under the Controlled Substances Act, Delaware pharmacies must receive a valid written or electronically transmitted prescription before dispensing it [3]. Verbal prescriptions for Schedule IV drugs are permitted under federal law in some circumstances, but most Delaware pharmacies require a paper or electronic order for modafinil specifically.

Generic manufacturers including Teva, Sun Pharma, and Mylan (now Viatris) entered the US market after the primary Cephalon patents expired. A 2023 analysis published through the FDA's Orange Book data confirms six approved generic modafinil products carrying an AB therapeutic equivalence rating, meaning they substitute freely for Provigil at the pharmacy counter [4].

At large Delaware chains, a 30-count supply of 200 mg generic modafinil typically ranges from $60 to $95 without any discount card. Splitting a prescription for 100 mg tablets and taking two at once does not change the pharmacology but may occasionally lower the copay depending on how a plan's formulary tiers the two strengths.

How Does Delaware Medicaid Cover Provigil and Generic Modafinil?

Delaware Medicaid (administered through Diamond State Health Plan managed-care organizations) covers generic modafinil with prior authorization (PA) for FDA-approved indications. Prior authorization requires documented diagnosis of narcolepsy, OSA residual sleepiness while on CPAP, or SWSD, along with a prescribing clinician's note supporting medical necessity [5].

The PA process generally takes three to seven business days. During that window, a prescriber may request a bridge supply through a peer-to-peer call with the plan's medical director. Delaware Medicaid does not routinely cover modafinil for off-label indications such as cognitive enhancement, cancer-related fatigue outside a clinical protocol, or ADHD, though individual appeals may succeed when supported by published evidence.

One 2021 systematic review in JAMA Internal Medicine found that prior authorization delays were associated with adverse clinical outcomes in roughly 25% of reviewed drug classes [6]. Narcolepsy and SWSD are time-sensitive conditions where untreated sleepiness raises workplace injury and motor vehicle accident risk, so submitting the PA with complete documentation the first time matters.

The Delaware Division of Medicaid and Medical Assistance (DMMA) publishes its preferred drug list (PDL) quarterly [7]. As of the most recent PDL cycle, generic modafinil sits in a preferred tier, meaning the PA burden is lower than it would be for brand-name Provigil, which is non-preferred and requires additional step-therapy documentation showing generic modafinil was tried or is contraindicated.

Clinicians submitting a PA for modafinil under Delaware Medicaid should include a sleep study report (polysomnography or MSLT for narcolepsy), CPAP compliance data if the indication is OSA residual sleepiness, or a shift-work schedule letter from an employer if the indication is SWSD [8].

Which Commercial Insurance Plans Cover Provigil in Delaware?

Most commercial plans sold through Delaware's ACA marketplace and employer-sponsored coverage include generic modafinil on tier 2 or tier 3, with copays ranging from about $20 to $60 per month after deductible. Brand-name Provigil typically sits on tier 4 or tier 5 (specialty), which can mean coinsurance of 25% to 40% of the $850 list price.

The major carriers active in Delaware include Highmark Delaware, Aetna (through CVS Health), and UnitedHealthcare. Each publishes a formulary search tool on its member portal where a patient can check the current tier placement and any PA or quantity-limit restrictions attached to modafinil.

The HealthRX Delaware Modafinil Coverage Framework gives patients a repeatable way to assess their out-of-pocket cost before the prescription is written:

1. Pull the current formulary from your insurer's member portal and confirm modafinil's tier.
2. Check whether a PA or quantity limit applies (most plans cap at 30 tablets per 30 days).
3. Ask your prescriber's office to submit the PA with the diagnosis code, supporting records, and a letter of medical necessity on the same day the prescription is written.
4. If the PA is denied, request a peer-to-peer review within 72 hours; approval rates after peer-to-peer are higher than first-submission rates across most plans.
5. If the drug remains unaffordable after approval, request a formulary exception citing the FDA-approved label and any supporting clinical data [9].

Delaware's Insurance Commissioner requires plans to respond to urgent PA requests within 72 hours and standard requests within three business days under state prompt-response rules, which align with the CMS Interoperability and Prior Authorization Final Rule finalized in January 2024 [10].

Is Compounded Modafinil Legal in Delaware, and How Much Does It Cost?

Compounded modafinil from a 503A pharmacy is legal in Delaware when prepared by a state-licensed compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber. The key legal framework is Section 503A of the Federal Food, Drug, and Cosmetic Act, which permits traditional compounding for individual patients [11].

Modafinil is not on the FDA's 503B outsourcing facility bulk-drug list, meaning large-scale commercial compounding by a 503B facility is not currently permitted. However, a neighborhood 503A pharmacy in Delaware may compound modafinil in non-standard doses, alternative delivery vehicles, or specialized formulations for patients with documented medical need.

Cost for compounded modafinil varies by pharmacy and formulation but is often substantially below the $80 generic cash price for patients who qualify. Some specialty compounding pharmacies work directly with telehealth platforms and may offer subscription pricing that includes the consultation fee.

Patients considering compounded modafinil should confirm three things before proceeding. First, the pharmacy must hold an active Delaware Board of Pharmacy license. Second, the prescribing clinician must document why the commercially available product does not meet the patient's clinical need. Third, insurance plans almost never cover compounded controlled substances, so cost-sharing benefits disappear.

The FDA has issued several warning letters to pharmacies compounding modafinil without valid prescriptions or in bulk quantities that suggest commercial rather than patient-specific intent [12]. Delaware residents should request a copy of the pharmacy's current state license and PCAB accreditation certificate before filling a compounded modafinil order.

Can Delaware Residents Get Modafinil Prescribed via Telehealth?

Yes. Telehealth prescribing of modafinil is permitted in Delaware for established patient-provider relationships, subject to the Ryan Haight Online Pharmacy Consumer Protection Act and the DEA's telemedicine prescribing rules [13].

Under the Ryan Haight Act, a prescriber must conduct at least one in-person medical evaluation before prescribing a Schedule IV controlled substance via telemedicine, unless a specific exception applies. The DEA's Special Registration for Telemedicine, proposed in 2023 and under ongoing rulemaking as of 2025, would create a pathway for certain providers to prescribe Schedule IV drugs through telemedicine without a prior in-person visit [14]. Until that rule is finalized, most Delaware telehealth platforms require either an initial in-person visit or a referral from a clinician who has already evaluated the patient.

Practical steps for Delaware residents seeking telehealth modafinil access include completing a sleep questionnaire (Epworth Sleepiness Scale score of 10 or higher warrants further evaluation), obtaining a diagnostic sleep study if narcolepsy or OSA is suspected, and then connecting with a board-certified sleep medicine physician or neurologist via a licensed Delaware telehealth platform [15].

HealthRX connects Delaware patients with clinicians licensed in Delaware who can review sleep study results, confirm a qualifying diagnosis, and manage ongoing modafinil therapy within the current federal and state prescribing framework.

What Are the Cheapest Ways to Get Modafinil in Delaware?

Generic modafinil at roughly $80 per month is already a fraction of the brand price. Several additional strategies can lower that further.

GoodRx and similar discount programs negotiate pharmacy-specific prices through pharmacy benefit manager contracts. At major Delaware chains, a GoodRx coupon for 30 tablets of 200 mg modafinil has reduced cash cost to as low as $45 in recent pricing checks. These coupons cannot be combined with insurance but can be used instead of insurance when the coupon price is lower than the copay.

Mark Cuban's Cost Plus Drugs (costplusdrugs.com) lists generic modafinil at a manufacturer cost-plus-15% model. Delaware patients with a valid prescription can order through Cost Plus Drugs and receive mail delivery, subject to Schedule IV mailing rules, which require an NABP-accredited mail pharmacy [16].

The Cephalon (now Jazz Pharmaceuticals) patient assistance program covers brand-name Provigil for uninsured patients whose household income falls below 400% of the federal poverty level [17]. Given that generic modafinil is therapeutically equivalent and far less expensive, the brand assistance program is primarily relevant when a patient has a documented generic intolerance or when a prescriber specifies brand-only for a clinical reason.

Some Delaware hospitals and federally qualified health centers (FQHCs) participate in the 340B Drug Pricing Program, which can make modafinil available at deeply discounted prices for qualifying low-income patients [18]. Delaware's 340B-covered entities include Christiana Care Health System outpatient clinics and several community health centers in Wilmington and Dover.

How Do Delaware Pharmacies Compare on Modafinil Price?

Prices vary more than most patients expect across the roughly 200 retail pharmacies operating in Delaware. CVS and Walgreens generally price 30 tablets of generic modafinil 200 mg between $75 and $95 before coupons. Walmart Pharmacy often prices it near $65. Independent pharmacies vary widely: some match big-chain prices, others run higher.

The Delaware Board of Pharmacy does not set or publish retail drug prices, so comparison shopping requires calling pharmacies directly or using a price-comparison tool such as GoodRx, NeedyMeds, or Blink Health [19]. Pharmacists are legally permitted to share cash prices over the phone without a prescription on file in Delaware.

One practical strategy: call three pharmacies in your ZIP code, provide the drug name (modafinil), strength (200 mg), and quantity (30 tablets), and ask for both the cash price and the price with your specific insurance card. The five-minute comparison call regularly saves $20 to $40 per fill.

What Clinical Evidence Supports Modafinil's Effectiveness?

The primary evidence for modafinil in narcolepsy comes from the key US Modafinil in Narcolepsy Study Group trial, published in Annals of Neurology in 1998 (N=271). Patients receiving modafinil 200 mg or 400 mg daily showed statistically significant improvement on the Maintenance of Wakefulness Test (P<0.001 vs. placebo) and clinically meaningful reductions in Epworth Sleepiness Scale scores [1].

For OSA residual sleepiness, a randomized controlled trial published in SLEEP (N=157) showed modafinil 200 mg reduced excessive daytime sleepiness scores significantly compared with placebo in patients already adherent to CPAP therapy [20]. The FDA label cites this trial in the OSA indication wording [2].

For SWSD, a randomized trial in the New England Journal of Medicine (N=278) found modafinil 200 mg taken before the night shift reduced sleepiness on the Karolinska Sleepiness Scale and improved performance on a cognitive vigilance task compared with placebo [21]. Mean Karolinska Sleepiness Scale improvement was 1.7 points greater in the modafinil arm (P<0.001).

Off-label use for cancer-related fatigue has weaker evidence. A 2010 Cochrane review of psychostimulants for cancer fatigue found modest benefit in patients with severe baseline fatigue but noted high heterogeneity across included trials [22]. Delaware Medicaid does not cover modafinil for this indication without individual appeal.

What Are the Safety Considerations and Drug Interactions Relevant to Delaware Prescribers?

Modafinil is generally well tolerated. The most common adverse effects reported in the FDA label include headache (34% vs. 23% placebo), nausea (11% vs. 3% placebo), nervousness, rhinitis, and diarrhea [2]. Serious but rare risks include serious rash (Stevens-Johnson syndrome has been reported), hypersensitivity reactions, and psychiatric symptoms including anxiety, agitation, and hallucination.

Modafinil is a moderate inducer of CYP3A4 and a weak inhibitor of CYP2C19 [2]. Delaware clinicians prescribing modafinil to patients on hormonal contraceptives should document that oral contraceptive efficacy may be reduced and recommend a barrier method during modafinil use and for one month after discontinuation. This interaction is clinically significant and is printed in the Provigil FDA label [2].

The American Academy of Sleep Medicine (AASM) clinical practice guidelines recommend modafinil as a first-line pharmacologic treatment for narcolepsy (Grade A), noting that "modafinil and armodafinil are recommended for the treatment of EDS in narcolepsy" [23]. The same guidelines support modafinil use in OSA-related residual sleepiness when CPAP adherence is confirmed [23].

Cardiovascular monitoring is warranted in patients with pre-existing cardiac conditions. A post-marketing study submitted to the FDA documented rare cases of left ventricular hypertrophy in patients with mitral valve prolapse taking modafinil [2]. Routine ECG before initiation is not required for otherwise healthy patients but should be considered in those with structural heart disease.

How Should Delaware Patients Approach a Modafinil Consultation?

Bring documentation. A sleep specialist or internist evaluating a patient for modafinil therapy needs either a polysomnography report (for narcolepsy or OSA), a multiple sleep latency test (MSLT) showing mean sleep latency of eight minutes or less with two or more sleep-onset REM periods for narcolepsy type 1, or employer shift records for SWSD [24].

Clinicians at HealthRX review these records before the consultation so the appointment focuses on treatment planning rather than document collection. Patients who arrive with a completed Epworth Sleepiness Scale (any score above 10 suggests excessive daytime sleepiness warranting investigation) and existing sleep study data move through evaluation fastest [15].

Once a qualifying diagnosis is established, the standard starting dose is modafinil 200 mg orally once in the morning for narcolepsy and OSA, or 200 mg taken approximately one hour before the start of a work shift for SWSD [2]. Doses above 400 mg per day have not shown additional benefit in controlled trials and are not recommended in the FDA label [2].

Delaware patients with a confirmed diagnosis, a valid prescription, and access to a GoodRx coupon at a Walmart Pharmacy in Wilmington or Dover can expect to pay approximately $45 to $65 per 30-day supply for generic modafinil 200 mg as of mid-2025 pricing data.